These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22102453)

  • 81. Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles.
    Serra A; Ruff RL; Leigh RJ
    Ann N Y Acad Sci; 2012 Dec; 1275(1):129-35. PubMed ID: 23278588
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Electrophysiological evaluation of the neuromuscular junction: a brief review.
    Kouyoumdjian JA; Estephan EP
    Arq Neuropsiquiatr; 2023 Dec; 81(12):1040-1052. PubMed ID: 38157872
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Morphological and functional alterations of neuromuscular synapses in a mouse model of ACTA1 congenital myopathy.
    Liu Y; Lin W
    Hum Mol Genet; 2024 Jan; 33(3):233-244. PubMed ID: 37883471
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The molecular athlete: exercise physiology from mechanisms to medals.
    Furrer R; Hawley JA; Handschin C
    Physiol Rev; 2023 Jul; 103(3):1693-1787. PubMed ID: 36603158
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Structure and Function of the Mammalian Neuromuscular Junction.
    Davis LA; Fogarty MJ; Brown A; Sieck GC
    Compr Physiol; 2022 Aug; 12(4):3731-3766. PubMed ID: 35950651
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The Donnan-dominated resting state of skeletal muscle fibers contributes to resilience and longevity in dystrophic fibers.
    Morris CE; Wheeler JJ; Joos B
    J Gen Physiol; 2022 Jan; 154(1):. PubMed ID: 34731883
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cholesterol and the Safety Factor for Neuromuscular Transmission.
    Krivoi II; Petrov AM
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30823359
    [TBL] [Abstract][Full Text] [Related]  

  • 88. AMP-Activated Protein Kinase as a Key Trigger for the Disuse-Induced Skeletal Muscle Remodeling.
    Vilchinskaya NA; Krivoi II; Shenkman BS
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424476
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Autoregulation of Acetylcholine Release and Micro-Pharmacodynamic Mechanisms at Neuromuscular Junction: Selective Acetylcholinesterase Inhibitors for Therapy of Myasthenic Syndromes.
    Petrov KA; Nikolsky EE; Masson P
    Front Pharmacol; 2018; 9():766. PubMed ID: 30050445
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Isoform-specific Na,K-ATPase alterations precede disuse-induced atrophy of rat soleus muscle.
    Kravtsova VV; Matchkov VV; Bouzinova EV; Vasiliev AN; Razgovorova IA; Heiny JA; Krivoi II
    Biomed Res Int; 2015; 2015():720172. PubMed ID: 25654120
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders.
    Bates ME; Buckman JF; Nguyen TT
    Neuropsychol Rev; 2013 Mar; 23(1):27-47. PubMed ID: 23412885
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
    Belaya K; Finlayson S; Cossins J; Liu WW; Maxwell S; Palace J; Beeson D
    Ann N Y Acad Sci; 2012 Dec; 1275():29-35. PubMed ID: 23278575
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.
    Belaya K; Finlayson S; Slater CR; Cossins J; Liu WW; Maxwell S; McGowan SJ; Maslau S; Twigg SR; Walls TJ; Pascual Pascual SI; Palace J; Beeson D
    Am J Hum Genet; 2012 Jul; 91(1):193-201. PubMed ID: 22742743
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Chronic nicotine modifies skeletal muscle Na,K-ATPase activity through its interaction with the nicotinic acetylcholine receptor and phospholemman.
    Chibalin AV; Heiny JA; Benziane B; Prokofiev AV; Vasiliev AV; Kravtsova VV; Krivoi II
    PLoS One; 2012; 7(3):e33719. PubMed ID: 22442718
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Endplate contributions to the safety factor for neuromuscular transmission.
    Ruff RL
    Muscle Nerve; 2011 Dec; 44(6):854-61. PubMed ID: 22102453
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles.
    Serra A; Ruff R; Kaminski H; Leigh RJ
    Ann N Y Acad Sci; 2011 Sep; 1233():26-33. PubMed ID: 21950972
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Electrophysiology of postsynaptic activation.
    Ruff RL
    Ann N Y Acad Sci; 1998 May; 841():57-70. PubMed ID: 9668221
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors.
    Oda K; Lambert EH; Lennon VA; Palmer AC
    Muscle Nerve; 1984; 7(9):705-16. PubMed ID: 6543919
    [TBL] [Abstract][Full Text] [Related]  

  • 99. How myasthenia gravis alters the safety factor for neuromuscular transmission.
    Ruff RL; Lennon VA
    J Neuroimmunol; 2008 Sep; 201-202():13-20. PubMed ID: 18632162
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Electrical exploration of acetylcholine receptors.
    Katz B
    Postgrad Med J; 1981; 57 Suppl 1():84-8. PubMed ID: 6272255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.